Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

307
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
307
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

895
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
895
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

317
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
317
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

638
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
638
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

461
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
461
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

438
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
438

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Population Approaches With Physiologically Based Pharmacokinetic Models: A Novel Framework for Parameter Estimation.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.

Nature medicine·2024
Same author

A joint analysis proposal of nonlinear longitudinal and time-to-event right-, interval-censored data for modeling pregnancy miscarriage.

Computers in biology and medicine·2024
Same author

Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment Trials.

Journal of Parkinson's disease·2024
Same author

Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia.

British journal of clinical pharmacology·2024
Same author

Artificial Intelligence and Disease Modeling: Focus on Neurological Disorders.

Clinical pharmacology and therapeutics·2024
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions.

Marc Lavielle1, Benjamin Ribba2

  • 1Inria Saclay & CMAP, Ecole Polytechnique, University Paris-Saclay, Saint-Aubin, France.

Pharmaceutical Research
|September 9, 2016
PubMed
Summary
This summary is machine-generated.

A new random sampling method improves diagnostics for nonlinear mixed-effects pharmacometric models. This approach offers more reliable results than empirical Bayes estimates (EBEs), especially with sparse data.

Keywords:
model diagnosticsmodeling and simulationpharmacokinetics and pharmacodynamics

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Area of Science:

  • Pharmacometrics
  • Statistical Modeling
  • Computational Biology

Background:

  • Nonlinear mixed-effects (NLME) models are crucial in pharmacometrics.
  • Model diagnostics often rely on empirical Bayes estimates (EBEs).
  • Sparse individual data can cause EBEs to "shrink," leading to misleading diagnostics.

Purpose of the Study:

  • To develop a novel diagnostic method for NLME models.
  • To address limitations of EBE-based diagnostics with sparse data.
  • To enhance the reliability of pharmacometric model evaluation.

Main Methods:

  • Proposed a random sampling approach for individual parameters instead of maximizing conditional distributions.
  • Evaluated the method using diagnostic plots and statistical tests.
  • Assessed performance against traditional EBE-based methods.

Main Results:

  • The proposed random sampling method yields more reliable diagnostic results.
  • Diagnostic plots become more meaningful and informative.
  • Type I error rates are controlled, and statistical power increases with misspecification.

Conclusions:

  • Random sampling offers a valuable complement to EBE-based approaches for NLME model diagnosis.
  • Implementation of this method can significantly improve model performance evaluation.
  • The approach demonstrates practical utility, as shown in warfarin pharmacokinetic data analysis.